Inactive Instrument

News Vitality Biopharma, Inc. Other OTC

Equities

VBIO

US92849B1070

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Range Impact Reports 1Q 2024 Financial Results	16/05	AQ
Range Impact Transitions Two Executives to Graphium Biosciences Subsidiary as Part of Proposed Divestiture and Promotes Corporate Controller to Chief Financial Officer	26/04	AQ
Range Impact, Inc. Announces Executive Changes	26/04	CI
Range Impact, Inc. Announces Chief Financial Officer Changes	26/04	CI
Range Impact, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/03	CI
Range Impact, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Range Impact Reports 4Q 2023 and Full Year 2023 Financial Results	29/03	AQ
Range Impact, Inc. Announces Executive Appointments	30/01	CI
Range Impact Announces Former Ohio Congressman Zack Space and Former Ohio Senator Jay Hottinger Have Joined the Company as Strategic Advisors	30/01	AQ
Range Impact Announces $1.7 Million Capital Raise Led by Strategic Investors	22/12	AQ
Range Impact, Inc. announced that it has received $1.7 million in funding	21/12	CI
Malachite Innovations Changes its Name to Range Impact and Adopts New Ticker Symbol “RNGE”	15/12	AQ
Malachite Innovations, Inc. has Changed its Name to Range Impact, Inc	14/12	CI
Malachite Innovations, Inc. has Changed its Ticker to RNGE from MLCT	14/12	CI
Malachite Innovations Retains Investment Banking Firm to Assist in Implementation of Strategic Plan for Cannabinoid Drug Development Business	07/12	AQ
Graphium Biosciences, Inc. announced that it expects to receive $4 million in funding from Range Impact, Inc.	07/12	CI
Earnings Flash (MLCT) MALACHITE INNOVATIONS Reports Q3 Revenue $5.5M	15/11	MT
Malachite Innovations, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
MALACHITE INNOVATIONS REPORTS THIRD QUARTER 2023 RESULTS	15/11	AQ
(MLCT) MALACHITE INNOVATIONS Expects Q4 Revenue $5.5M	15/11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Vitality Biopharma, Inc. Other OTC

Equities

VBIO

US92849B1070

Summary

Filters